Insider · CIK 0001595612
Daniel J. Brennan
Files at BSX (BOSTON SCIENTIFIC CORP), WAT (WATERS CORP /DE/). First filing Jan 3, 2025, latest Feb 19, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BSX: BOSTON SCIENTIFIC CORP
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 37Weak | sell 710b5-1 | BSX BOSTON SCIENTIFIC CORP | $8.9M | 84,863 | -34% | - | |
| 27Weak | sell 710b5-1 | BSX BOSTON SCIENTIFIC CORP | $1.6M | 15,087 | -6% | - | |
| 25Weak | sell 310b5-1 | BSX BOSTON SCIENTIFIC CORP | $871k | 9,689 | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 18, 2025 | BSX BOSTON SCIENTIFIC CORP | SOpen-market sale Common Stock10b5-1 | -2,900 | $104.08 | $302k | 247,248 | Feb 19, 2025 |
| Feb 18, 2025 | BSX BOSTON SCIENTIFIC CORP | SOpen-market sale Common Stock10b5-1 | -14,630 | $104.67 | $1.5M | 232,618 | Feb 19, 2025 |
| Feb 19, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Common Stock10b5-1 | +18,533 | $24.55 | $455k | 251,151 | Feb 19, 2025 |
| Feb 19, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Common Stock10b5-1 | +16,865 | $17.26 | $291k | 268,016 | Feb 19, 2025 |
| Feb 19, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Common Stock10b5-1 | +15,642 | $27.09 | $424k | 283,658 | Feb 19, 2025 |
| Feb 19, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Common Stock10b5-1 | +9,483 | $40.12 | $380k | 293,141 | Feb 19, 2025 |
| Feb 19, 2025 | BSX BOSTON SCIENTIFIC CORP | SOpen-market sale Common Stock10b5-1 | -67,333 | $105.24 | $7.1M | 225,808 | Feb 19, 2025 |
| Feb 19, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,642 | $0.00 | $0 | 31,285 | Feb 19, 2025 |
| Feb 19, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -9,483 | $0.00 | $0 | 37,934 | Feb 19, 2025 |
| Feb 19, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -16,865 | $0.00 | $0 | 0 | Feb 19, 2025 |
| Feb 19, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -18,533 | $0.00 | $0 | 37,067 | Feb 19, 2025 |
| Feb 14, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Common Stock | +4,362 | $0.00 | $0 | 247,700 | Feb 18, 2025 |
| Feb 14, 2025 | BSX BOSTON SCIENTIFIC CORP | FTax withholding Common Stock | -2,110 | $106.11 | $224k | 245,590 | Feb 18, 2025 |
| Feb 16, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Common Stock | +4,243 | $0.00 | $0 | 249,833 | Feb 18, 2025 |
| Feb 16, 2025 | BSX BOSTON SCIENTIFIC CORP | FTax withholding Common Stock | -2,052 | $106.11 | $218k | 247,781 | Feb 18, 2025 |
| Feb 17, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Common Stock | +4,584 | $0.00 | $0 | 252,365 | Feb 18, 2025 |
| Feb 17, 2025 | BSX BOSTON SCIENTIFIC CORP | FTax withholding Common Stock | -2,217 | $106.11 | $235k | 250,148 | Feb 18, 2025 |
| Feb 13, 2025 | BSX BOSTON SCIENTIFIC CORP | AGrant or award Restricted Stock Unitsderivative | +8,950 | $0.00 | $0 | 8,950 | Feb 18, 2025 |
| Feb 13, 2025 | BSX BOSTON SCIENTIFIC CORP | AGrant or award Stock Option (Right to Buy)derivative | +23,031 | $0.00 | $0 | 23,031 | Feb 18, 2025 |
| Feb 14, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Restricted Stock Unitsderivative | -4,362 | $0.00 | $0 | 8,725 | Feb 18, 2025 |
| Feb 16, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Restricted Stock Unitsderivative | -4,243 | $0.00 | $0 | 4,243 | Feb 18, 2025 |
| Feb 17, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Restricted Stock Unitsderivative | -4,584 | $0.00 | $0 | 0 | Feb 18, 2025 |
| Feb 12, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Common Stock | +3,654 | $0.00 | $0 | 245,105 | Feb 14, 2025 |
| Feb 12, 2025 | BSX BOSTON SCIENTIFIC CORP | FTax withholding Common Stock | -1,767 | $105.77 | $187k | 243,338 | Feb 14, 2025 |
| Feb 12, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Restricted Stock Unitsderivative | -3,654 | $0.00 | $0 | 10,963 | Feb 14, 2025 |
| Feb 11, 2025 | BSX BOSTON SCIENTIFIC CORP | AGrant or award Common Stock10b5-1 | +33,944 | $0.00 | $0 | 257,865 | Feb 13, 2025 |
| Feb 11, 2025 | BSX BOSTON SCIENTIFIC CORP | FTax withholding Common Stock10b5-1 | -16,414 | $105.98 | $1.7M | 241,451 | Feb 13, 2025 |
| Feb 12, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Common Stock10b5-1 | +15,087 | $16.31 | $246k | 256,538 | Feb 13, 2025 |
| Feb 12, 2025 | BSX BOSTON SCIENTIFIC CORP | SOpen-market sale Common Stock10b5-1 | -15,087 | $105.07 | $1.6M | 241,451 | Feb 13, 2025 |
| Feb 12, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -15,087 | $0.00 | $0 | 0 | Feb 13, 2025 |
| Jan 2, 2025 | WAT WATERS CORP /DE/ | AGrant or award Common Stock | +319 | $0.00 | $0 | 1,025 | Jan 6, 2025 |
| Jan 2, 2025 | WAT WATERS CORP /DE/ | AGrant or award Stock Option (Right to Buy)derivative | +818 | $0.00 | $0 | 818 | Jan 6, 2025 |
| Jan 1, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Common Stock10b5-1 | +14,901 | $0.00 | $0 | 238,822 | Jan 3, 2025 |
| Jan 1, 2025 | BSX BOSTON SCIENTIFIC CORP | FTax withholding Common Stock10b5-1 | -5,212 | $89.32 | $466k | 233,610 | Jan 3, 2025 |
| Jan 3, 2025 | BSX BOSTON SCIENTIFIC CORP | SOpen-market sale Common Stock10b5-1 | -9,689 | $89.86 | $871k | 223,921 | Jan 3, 2025 |
| Jan 1, 2025 | BSX BOSTON SCIENTIFIC CORP | MOption exercise Performance Share Unitsderivative10b5-1 | -14,901 | $0.00 | $0 | 0 | Jan 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.